RECURSION PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
Pre-market 12:39:12 | |||
| 6.910 USD | +2.22% |
|
7.180 | +3.91% |
| 09-03 | Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating | MT |
| 09-03 | Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 7.890 | 7.890 | 13.37 |
| Spread/Res. | -12.42% | -12.42% | -48.32% |
| Spread/Supp. | +16.72% | +16.72% | +30.87% |
| Support | 5.920 | 5.920 | 5.280 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition